• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RGS
Click for more information
0.00% 12.0¢

REGENEUS LTD

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight

A regenerative medicine company, using stem cell and immuno-oncology technologies to develop a portfolio of cell-based therapies to address unmet medical needs in the human and animal health markets with a focus on osteoarthritis & other musculoskeletal disorders, oncology and dermatology diseases.
View the full Corporate Spotlight arrow Created with Sketch.

Regeneus achieves major milestones

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RGS
Still no deal?!? 		18/03/19 54 14K
18/03/19 Last post  findingnemo Comments Created with Sketch.  54  Views Created with Sketch.  14K 
RGS
Ann: Directors Provide $2.5M Loan to Extend Funding Runway 		08/03/19 6 1.4K
08/03/19 Last post  TDA Comments Created with Sketch.  6  Views Created with Sketch.  1.4K 
RGS
Ann: Appendix 4D and Half-Year Report 		28/02/19 0 159
28/02/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  159 
RGS
News: RGS Regeneus Board Provides Loan Funding Of $2.5 Mln 		28/02/19 0 123
28/02/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  123 
RGS
Ann: Response to ASX Appendix 4C Query Letter 		22/02/19 2 748
22/02/19 Last post  zeno9 Comments Created with Sketch.  2  Views Created with Sketch.  748 
RGS
Ann: New CEO Appointed to Accelerate Global Growth 		19/02/19 21 4.5K
19/02/19 Last post  zeno9 Comments Created with Sketch.  21  Views Created with Sketch.  4.5K 
RGS
Ann: Material Terms of Contract for Chief Executive Officer 		01/02/19 1 434
01/02/19 Last post  panorama Comments Created with Sketch.  1  Views Created with Sketch.  434 
RGS
4C 		30/01/19 0 239
30/01/19 Last post  bang57 Comments Created with Sketch.  0  Views Created with Sketch.  239 
RGS
Ann: Appendix 4C - Quarterly 		30/01/19 0 211
30/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  211 
RGS
News: RGS Regeneus Appointed Leo Lee As CEO 		23/01/19 0 187
23/01/19 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  187 
RGS
Interesting article 		07/12/18 6 1.2K
07/12/18 Last post  Dufrane Comments Created with Sketch.  6  Views Created with Sketch.  1.2K 
RGS
RGS (ASX) Corporate Spotlight Updates 		03/12/18 2 577
03/12/18 Last post  Corporate Spotlight Comments Created with Sketch.  2  Views Created with Sketch.  577 
RGS
Ann: Chinese patent granted for biomarkers for stem cell therapy 		03/12/18 2 937
03/12/18 Last post  happydad Comments Created with Sketch.  2  Views Created with Sketch.  937 
RGS
News: RGS Regeneus Says Chinese Patent Granted For Biomarkers To Monitor Disease Progression For... 		03/12/18 0 152
03/12/18 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  152 
RGS
Ann: Update on licensing Progenza in Japan 		27/11/18 32 8.2K
27/11/18 Last post  aruc6393 Comments Created with Sketch.  32  Views Created with Sketch.  8.2K 
RGS
Ann: CEO Presentation to 2018 Annual General Meeting 		22/11/18 4 1.0K
22/11/18 Last post  Biotechasx Comments Created with Sketch.  4  Views Created with Sketch.  1.0K 

See All Discussions arrow Created with Sketch.

Corporate Spotlight

Top Stories

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
PhosCo inks MOU with Tunisian gov't, EU bank paving way to Gassaat fert project PhosCo (ASX:PHO) has confirmed its execution of an MOU with the government of Tunisia as its Gassaat permit is approved.
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.